ES2045160T3 - Derivados de acilaminometil-3 tetrahidro-5,6,7,8 imidazo-(1,2-a)-piridinas, su preparacion y su aplicacion en terapeutica. - Google Patents

Derivados de acilaminometil-3 tetrahidro-5,6,7,8 imidazo-(1,2-a)-piridinas, su preparacion y su aplicacion en terapeutica.

Info

Publication number
ES2045160T3
ES2045160T3 ES88401186T ES88401186T ES2045160T3 ES 2045160 T3 ES2045160 T3 ES 2045160T3 ES 88401186 T ES88401186 T ES 88401186T ES 88401186 T ES88401186 T ES 88401186T ES 2045160 T3 ES2045160 T3 ES 2045160T3
Authority
ES
Spain
Prior art keywords
therapeutics
application
piridinas
acilaminometil
tetrahidro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88401186T
Other languages
English (en)
Inventor
Pascal George
Claudie Giron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Application granted granted Critical
Publication of ES2045160T3 publication Critical patent/ES2045160T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPUESTOSM BAJO FORMA DE ENANTIOMEROS PUROS O DE MEZCLAS DE ENANTIOMEROS QUE RESPONDEN A LA FORMULA (I) EN LA QUE LOS SUSTITUYENTES TIENEN ELSIGNIFICADO QUE SE DETALLA EN LAINVENCION. APLICACION EN TERAPEUTICA.
ES88401186T 1987-05-21 1988-05-17 Derivados de acilaminometil-3 tetrahidro-5,6,7,8 imidazo-(1,2-a)-piridinas, su preparacion y su aplicacion en terapeutica. Expired - Lifetime ES2045160T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8707125A FR2615513B1 (fr) 1987-05-21 1987-05-21 Derives d'acylaminomethyl-3 tetrahydro-5,6,7,8 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ES2045160T3 true ES2045160T3 (es) 1994-01-16

Family

ID=9351291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88401186T Expired - Lifetime ES2045160T3 (es) 1987-05-21 1988-05-17 Derivados de acilaminometil-3 tetrahidro-5,6,7,8 imidazo-(1,2-a)-piridinas, su preparacion y su aplicacion en terapeutica.

Country Status (21)

Country Link
US (1) US4904670A (es)
EP (1) EP0295161B1 (es)
JP (1) JPH01151580A (es)
KR (1) KR880013900A (es)
AR (1) AR242575A1 (es)
AT (1) ATE82288T1 (es)
AU (1) AU600826B2 (es)
CA (1) CA1324140C (es)
DE (1) DE3875807T2 (es)
DK (1) DK168214B1 (es)
ES (1) ES2045160T3 (es)
FI (1) FI86726C (es)
FR (1) FR2615513B1 (es)
GR (1) GR3006813T3 (es)
HU (1) HU197901B (es)
IE (1) IE62224B1 (es)
IL (1) IL86444A (es)
NO (1) NO166128C (es)
NZ (1) NZ224728A (es)
PT (1) PT87546B (es)
ZA (1) ZA883614B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
FR2778564B1 (fr) * 1998-05-13 2001-07-13 Sanofi Sa Utilisation de composes reduisant l'apoptose

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568880B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2593818B1 (fr) * 1986-02-05 1988-04-29 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
EP0234970B1 (fr) * 1986-01-22 1991-04-17 Synthelabo Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
FR2593817B1 (fr) * 1986-01-31 1988-04-15 Synthelabo Derives de tetrahydro-5,6,7,8 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires

Also Published As

Publication number Publication date
DE3875807D1 (de) 1992-12-17
AU600826B2 (en) 1990-08-23
FI86726B (fi) 1992-06-30
FR2615513A1 (fr) 1988-11-25
NO882201L (no) 1988-11-22
DK276888A (da) 1988-11-22
JPH01151580A (ja) 1989-06-14
US4904670A (en) 1990-02-27
GR3006813T3 (es) 1993-06-30
IE881533L (en) 1988-11-21
DE3875807T2 (de) 1993-05-27
EP0295161B1 (fr) 1992-11-11
EP0295161A1 (fr) 1988-12-14
FR2615513B1 (fr) 1989-07-13
IL86444A0 (en) 1988-11-15
NO882201D0 (no) 1988-05-20
PT87546A (pt) 1989-05-31
FI882383A (fi) 1988-11-22
FI86726C (fi) 1992-10-12
NZ224728A (en) 1989-10-27
DK168214B1 (da) 1994-02-28
IL86444A (en) 1992-02-16
AR242575A1 (es) 1993-04-30
CA1324140C (en) 1993-11-09
AU1658288A (en) 1988-11-24
ZA883614B (en) 1989-01-25
IE62224B1 (en) 1995-01-11
PT87546B (pt) 1992-09-30
NO166128C (no) 1991-06-05
DK276888D0 (da) 1988-05-20
HU197901B (en) 1989-06-28
NO166128B (no) 1991-02-25
ATE82288T1 (de) 1992-11-15
FI882383A0 (fi) 1988-05-20
HUT47109A (en) 1989-01-30
KR880013900A (ko) 1988-12-22

Similar Documents

Publication Publication Date Title
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
MX9202996A (es) Diazabiciclo-(3-3-1)nonanos.
ES2059491T3 (es) Derivados de indol con anillos condensados.
DE3267352D1 (en) Novel aroylimidazolones
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
DE69209787T2 (de) Herstellung von Pigmentzusammensetzungen
ES2093666T3 (es) Derivados de los acidos 7-(2,7-diazabiciclo(3,3.0)octil)-3-quinolon- y -naftiridon carboxilicos.
AR241022A2 (es) "fosfatidos de eteres de glicerina y procedimiento para su preparacion"
ES2045160T3 (es) Derivados de acilaminometil-3 tetrahidro-5,6,7,8 imidazo-(1,2-a)-piridinas, su preparacion y su aplicacion en terapeutica.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2103104T3 (es) Nuevos compuestos di- y poliaminicos utiles en la preparacion de poliuretanos.
ATE120718T1 (de) Herstellung von peroxidzusammensetzungen.
DE3855121D1 (de) Anxiolytisch wirksame Piperazinderivate
ATE92070T1 (de) Azachromanderivate.
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
DE3779991D1 (de) Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen.
FR2372805A1 (es)
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
FR2429202A1 (es)
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
DE3686793T2 (de) Behandlung der reaktionsmischung bei der herstellung von natriumdithionit.
DE69000259T2 (de) Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure.
SE8505801L (sv) I,4-dihydropyridin-derivat, deras framstellning och farmaceutiska beredningar innehallande dessa
ES2067417B1 (es) Procedimiento para preparar nuevos derivados en n de (feniletil-beta-ol)-amina.
IT1119156B (it) Procedimento per la preparazione di 2 alcossi 4 6 dicloro s triazine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 295161

Country of ref document: ES